Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026836588> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2026836588 endingPage "325" @default.
- W2026836588 startingPage "322" @default.
- W2026836588 abstract "Fibroblast growth factor receptor 3 (FGFR3) protein is aberrantly expressed in approximately 15% of cases of plasma cell myeloma as a result of t(4;14)(p16.3;q32), and FGFR3 expression in myeloma is associated with an adverse prognosis. Novel, recently developed therapeutic agents that target the FGFR3 pathway are currently in clinical trials for myeloma. Although extensively studied in plasma cell neoplasms, there is little information in the literature regarding FGFR3 expression in malignant lymphomas, and it is unclear whether lymphoma patients may also benefit from anti-FGFR3 therapy. We, therefore, examined the expression of FGFR3 by immunohistochemistry in 70 cases of malignant lymphoma using tissue microarrays and whole paraffin sections. Of 22 cases of plasma cell myeloma analyzed as controls, FGFR3 positivity was seen in 3/5 t(4;14) positive cases (60%) and in none of 17 t(4;14) negative cases (P=0.006). Weak-to-moderate cytoplasmic FGFR3 staining was seen in 6/43 (12%) B-cell non-Hodgkin lymphomas and 2/17 (12%) T-cell lymphomas, with staining observed at low incidence in many histologic types. Cytoplasmic staining was also seen infrequently in classic Hodgkin lymphoma (1/10, 10%). Membrane staining was not observed in any case of malignant lymphoma. These results indicate that aberrant FGFR3 staining may be seen infrequently in many forms of malignant lymphoma, although dysregulation of this pathway does not seem to contribute to lymphomagenesis in the majority of cases. Moreover, these findings suggest at least most patients with malignant lymphomas are unlikely to benefit from novel agents targeting the FGFR3 pathway." @default.
- W2026836588 created "2016-06-24" @default.
- W2026836588 creator A5018462631 @default.
- W2026836588 creator A5066731616 @default.
- W2026836588 date "2008-07-01" @default.
- W2026836588 modified "2023-09-26" @default.
- W2026836588 title "Fibroblast Growth Factor Receptor 3 (FGFR3) Expression in Malignant Lymphomas" @default.
- W2026836588 cites W1563019250 @default.
- W2026836588 cites W1568606301 @default.
- W2026836588 cites W161204680 @default.
- W2026836588 cites W1984145333 @default.
- W2026836588 cites W1990338764 @default.
- W2026836588 cites W1995246165 @default.
- W2026836588 cites W1999539429 @default.
- W2026836588 cites W2011496893 @default.
- W2026836588 cites W201957249 @default.
- W2026836588 cites W2025886884 @default.
- W2026836588 cites W2026721058 @default.
- W2026836588 cites W2027359959 @default.
- W2026836588 cites W2037538447 @default.
- W2026836588 cites W2052337699 @default.
- W2026836588 cites W2054290966 @default.
- W2026836588 cites W2055428558 @default.
- W2026836588 cites W2057976029 @default.
- W2026836588 cites W2059494778 @default.
- W2026836588 cites W2061196972 @default.
- W2026836588 cites W2065628269 @default.
- W2026836588 cites W2075175917 @default.
- W2026836588 cites W2088123597 @default.
- W2026836588 cites W2096844711 @default.
- W2026836588 cites W2104452168 @default.
- W2026836588 cites W2106838577 @default.
- W2026836588 cites W2138178479 @default.
- W2026836588 cites W2152507719 @default.
- W2026836588 cites W2166508172 @default.
- W2026836588 doi "https://doi.org/10.1097/pai.0b013e31815ace54" @default.
- W2026836588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18528286" @default.
- W2026836588 hasPublicationYear "2008" @default.
- W2026836588 type Work @default.
- W2026836588 sameAs 2026836588 @default.
- W2026836588 citedByCount "5" @default.
- W2026836588 countsByYear W20268365882012 @default.
- W2026836588 crossrefType "journal-article" @default.
- W2026836588 hasAuthorship W2026836588A5018462631 @default.
- W2026836588 hasAuthorship W2026836588A5066731616 @default.
- W2026836588 hasConcept C126322002 @default.
- W2026836588 hasConcept C142724271 @default.
- W2026836588 hasConcept C147708747 @default.
- W2026836588 hasConcept C170493617 @default.
- W2026836588 hasConcept C193270364 @default.
- W2026836588 hasConcept C204232928 @default.
- W2026836588 hasConcept C2776364478 @default.
- W2026836588 hasConcept C2779338263 @default.
- W2026836588 hasConcept C2780007613 @default.
- W2026836588 hasConcept C2908937092 @default.
- W2026836588 hasConcept C502942594 @default.
- W2026836588 hasConcept C71924100 @default.
- W2026836588 hasConcept C74373430 @default.
- W2026836588 hasConcept C74864618 @default.
- W2026836588 hasConceptScore W2026836588C126322002 @default.
- W2026836588 hasConceptScore W2026836588C142724271 @default.
- W2026836588 hasConceptScore W2026836588C147708747 @default.
- W2026836588 hasConceptScore W2026836588C170493617 @default.
- W2026836588 hasConceptScore W2026836588C193270364 @default.
- W2026836588 hasConceptScore W2026836588C204232928 @default.
- W2026836588 hasConceptScore W2026836588C2776364478 @default.
- W2026836588 hasConceptScore W2026836588C2779338263 @default.
- W2026836588 hasConceptScore W2026836588C2780007613 @default.
- W2026836588 hasConceptScore W2026836588C2908937092 @default.
- W2026836588 hasConceptScore W2026836588C502942594 @default.
- W2026836588 hasConceptScore W2026836588C71924100 @default.
- W2026836588 hasConceptScore W2026836588C74373430 @default.
- W2026836588 hasConceptScore W2026836588C74864618 @default.
- W2026836588 hasIssue "4" @default.
- W2026836588 hasLocation W20268365881 @default.
- W2026836588 hasLocation W20268365882 @default.
- W2026836588 hasOpenAccess W2026836588 @default.
- W2026836588 hasPrimaryLocation W20268365881 @default.
- W2026836588 hasRelatedWork W1992481203 @default.
- W2026836588 hasRelatedWork W1993946980 @default.
- W2026836588 hasRelatedWork W2013745628 @default.
- W2026836588 hasRelatedWork W2021173905 @default.
- W2026836588 hasRelatedWork W2035464821 @default.
- W2026836588 hasRelatedWork W2060050787 @default.
- W2026836588 hasRelatedWork W2381735876 @default.
- W2026836588 hasRelatedWork W2386812150 @default.
- W2026836588 hasRelatedWork W2390523857 @default.
- W2026836588 hasRelatedWork W50742768 @default.
- W2026836588 hasVolume "16" @default.
- W2026836588 isParatext "false" @default.
- W2026836588 isRetracted "false" @default.
- W2026836588 magId "2026836588" @default.
- W2026836588 workType "article" @default.